Dasatinib: In Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
- Published in:
- BioDrugs, 2008, v. 22, n. 1, p. 59, doi. 10.2165/00063030-200822010-00007
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2008 AND VI 22 AND IP 1
Results: 7
1
2
Ribonucleases as Novel Chemotherapeutics: The Ranpirnase Example.
- Published in:
- BioDrugs, 2008, v. 22, n. 1, p. 53, doi. 10.2165/00063030-200822010-00006
- By:
- Publication type:
- Article
3
Vaccine Approaches to Prevent and Treat Prion Infection: Progress and Challenges.
- Published in:
- BioDrugs, 2008, v. 22, n. 1, p. 45
- By:
- Publication type:
- Article
4
Fibroblast Growth Factor-21 as a Therapeutic Agent for Metabolic Diseases.
- Published in:
- BioDrugs, 2008, v. 22, n. 1, p. 37, doi. 10.2165/00063030-200822010-00004
- By:
- Publication type:
- Article
5
Targeted Immunotherapy for Staphylococcal Infections: Focus on Anti-MSCRAMM Antibodies.
- Published in:
- BioDrugs, 2008, v. 22, n. 1, p. 27, doi. 10.2165/00063030-200822010-00003
- By:
- Publication type:
- Article
6
Fc-Based Cytokines: Prospects for Engineering Superior Therapeutics.
- Published in:
- BioDrugs, 2008, v. 22, n. 1, p. 11, doi. 10.2165/00063030-200822010-00002
- By:
- Publication type:
- Article
7
Convergence of Nanotechnology and Cardiovascular Medicine: Progress and Emerging Prospects.
- Published in:
- BioDrugs, 2008, v. 22, n. 1, p. 1, doi. 10.2165/00063030-200822010-00001
- By:
- Publication type:
- Article